BC
Brandon Couillard Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Agilent Technologies
A
$36.5B
| $128.75 | $140 |
9%
upside
| Overweight | 10 days ago |
|
2
CareDx
CDNA
$736M
| $13.82 | $14 |
1%
upside
| Equal-Weight | 29 days ago |
|
3
Mesa Laboratories
MLAB
$356M
| $64.75 | $67 |
3%
upside
| Equal-Weight | 1 month ago |
|
4
Waters Corp
WAT
$18.2B
| $306.32 | $315 |
3%
upside
| Equal-Weight | 1 month ago |
|
5
Bruker
BRKR
$4.68B
| $30.83 | $50 |
62%
upside
| Overweight | 1 month ago |
|
|
6
Bruker
BRKR
$4.68B
| $30.83 | $60 |
95%
upside
| Buy | 1 month ago |
|
7
Avantor
AVTR
$9.07B
| $13.31 | $16 |
20%
upside
| Overweight | 1 month ago |
|
8
Bio-Rad Laboratories Class A
BIO
$8B
| $295.43 | $265 |
10%
downside
| Equal-Weight | 1 month ago |
|
9
Repligen
RGEN
$7.01B
| $124.56 | $175 |
40%
upside
| Overweight | 1 month ago |
|
10
GeneDx Holdings
WGS
$3.81B
| $132.54 | $95 |
28%
downside
| Equal-Weight | 1 month ago |
|
11
Thermo Fisher Scientific
TMO
$186B
| $492.60 | $565 |
15%
upside
| Overweight | 1 month ago |
|
12
Danaher
DHR
$143B
| $200.21 | $205 |
2%
upside
| Equal-Weight | 1 month ago |
|
13
Bio-Techne
TECH
$8.46B
| $54.41 | $59 |
8%
upside
| Overweight | 3 months ago |
|
14
Myriad Genetics
MYGN
$615M
| $6.61 | $6 |
9%
downside
| Equal-Weight | 4 months ago |
|
15
Mettler-Toledo International
MTD
$26.9B
| $1,305.71 | $1,200 |
8%
downside
| Equal-Weight | 4 months ago |
|
|
16
Agilent Technologies
A
$36.5B
| $128.75 | $116 |
10%
downside
| Hold | 4 months ago |
|
17
Revvity
RVTY
$10.1B
| $86.64 | $102 |
18%
upside
| Equal-Weight | 4 months ago |
|
18
Align Technology
ALGN
$10.1B
| $139.12 | $260 |
87%
upside
| Buy | 7 months ago |
|
19
Henry Schein
HSIC
$8.42B
| $69.43 | $80 |
15%
upside
| Hold | 7 months ago |
|
20
Exact Sciences
EXAS
$10.2B
| $53.81 | $85 |
58%
upside
| Buy | 10 months ago |
|
|
21
Exact Sciences
EXAS
$10.2B
| $53.81 | $75 |
39%
upside
| Overweight | 1 year ago |
|
22
Maravai LifeSciences
MRVI
$363M
| $2.51 | $10 |
298%
upside
| Overweight | 1 year ago |
|
23
Envista
NVST
$3.54B
| $21.31 | $23 |
8%
upside
| Hold | 1 year ago |
|
|
24
Bio-Rad Laboratories Class A
BIO
$8B
| $295.43 | $725 |
145%
upside
| Buy | 4 years ago |
|